Careprost eyelash serum is an ophthalmic solution in which the active ingredient, bimatoprost 0.03%, belongs to the synthetic prostaglandin analogue class. A licence has been granted for its use in managing raised eye pressure and open-angle glaucoma. It is also used to treat hypotrichosis, a condition causing abnormally thin or sparse eyelashes. A GP or ophthalmologist must prescribe it.
Many patients in the UK are prescribed bimatoprost without knowing the brand names available. You may see, Lumigan, or other formulations at your pharmacy.
If your GP or ophthalmologist has recommended this medicine, understanding how it works is important. Knowing the purpose and risks helps you use it safely.
This guide explains what Careprost eyelash serum is, how bimatoprost works in the body, and what to expect during treatment. It covers both therapeutic and licensed ophthalmic uses within the UK regulatory context.
What Is Careprost Eyelash Serum?
Careprost — which contains bimatoprost 0.03% — carries prescription-only medicine (POM) classification. Intraocular pressure reduction in glaucoma is the primary reason it is prescribed. Hypotrichosis — a condition in which the eyelashes grow insufficiently — is another condition for which it is prescribed.
Careprost eyelash serum is an ophthalmic solution. Its active ingredient is bimatoprost 0.03%, a synthetic prostaglandin analogue. It works directly on the eye and the eyelid margin.
In the UK, bimatoprost products are prescription-only medicines. They are regulated by the MHRA. Before supply is permitted, UK law requires that a valid prescription be issued by a registered prescriber.
Lumigan is the most commonly prescribed reference brand among ophthalmologists in the UK. The same active ingredient is found in Careprost, making it an alternative to the reference brand. Both require a prescription.
| Category | Information |
|---|---|
| Drug class | Synthetic prostaglandin analogue |
| Active ingredient | Bimatoprost |
| Strength | 0.03% ophthalmic solution |
| Prescription status | Prescription-only medicine (POM) — UK |
| Primary therapeutic use | Open-angle glaucoma; ocular hypertension |
| Secondary licensed use | Hypotrichosis of the eyelashes |
| UK reference brand | Lumigan (Allergan) |
How Bimatoprost Works in the Body
Bimatoprost mimics a naturally occurring substance called prostamide. Intraocular pressure falls as fluid drainage from within the eye is improved by bimatoprost. Application along the eyelid margin prolongs the eyelash growth phase, resulting in lashes that are fuller and longer.
Prostamide receptors within the eye are targeted by bimatoprost, triggering its therapeutic action. As a result, the outflow of aqueous humour — the fluid contained within the eye — is increased. Lowering this fluid reduces intraocular pressure.
Raised intraocular pressure is the main risk factor in open-angle glaucoma. Optic nerve damage is less likely to occur when intraocular pressure is kept at a lower level. Regular use can slow the progression of vision loss.
Hair follicles along the upper eyelid margin are directly stimulated upon application of bimatoprost.
The anagen phase — the period during which eyelashes actively grow — is prolonged by this action. Over time, lashes become noticeably thicker, longer, and darker as a result.
Visible improvement in eyelash appearance develops gradually with continued use. Most patients notice a change after eight weeks of consistent use. Regular application is required to maintain the treatment effect.
When Doctors Prescribe Careprost Eyelash Serum
Doctors in the UK prescribe bimatoprost for two main licensed indications. These are managed by different specialists depending on the condition.
Open-Angle Glaucoma
The optic nerve sustains progressive damage as open-angle glaucoma advances. When open-angle glaucoma goes untreated, irreversible loss of vision is the likely result. Bimatoprost eye drops help reduce intraocular pressure in these patients.
Ophthalmologists typically prescribe bimatoprost as a first or second-line treatment. It is suitable as a sole therapy or in combination with other pressure-lowering eye medicines, depending on clinical need. Regular monitoring is required during treatment.
Ocular Hypertension
Pressure inside the eye that sits above the accepted normal range is what defines a diagnosis of ocular hypertension. It does not always cause symptoms. However, it raises the risk of developing glaucoma without treatment.
Bimatoprost reduces this pressure to protect the optic nerve. Each person’s risk profile is assessed before a treatment decision is made. Your ophthalmologist will assess whether medicine is needed.
Hypotrichosis of the Eyelashes
Hypotrichosis is a condition in which eyelashes grow poorly or are insufficient. This may result from certain medical conditions or treatments. Sparse lashes reduce the protection of the eye from debris and particles.
When applied to the upper eyelid margin, bimatoprost is recognised as a licensed treatment for eyelash improvement in several countries. In the UK, prescribers must assess individual suitability before recommending it.
Benefits of Careprost Eyelash Serum
The primary benefit of bimatoprost is its role in managing raised intraocular pressure. In patients with glaucoma, this reduces the risk of irreversible optic nerve damage. This helps preserve long-term vision.
Ocular hypertension is less likely to advance to glaucoma when treatment is initiated promptly. Early treatment with bimatoprost is an effective preventive strategy. Your ophthalmologist will confirm whether it is appropriate for you.
In patients with hypotrichosis, bimatoprost can produce visible improvement in eyelash density and length. Its effectiveness for this licensed indication is backed by clinical evidence. The hair follicle’s natural growth cycle is prolonged through its mechanism of action.
Unlike cosmetic products such as false lashes or extensions, bimatoprost targets the hair follicle itself. The improvement is due to biological action on the hair follicle, not topical cosmetic effect. However, the effect requires continued use to be maintained.
Alternative Medicine Doctors May Consider
Among the prostaglandin analogues available for glaucoma treatment, bimatoprost is one widely used option. Alternatives include latanoprost and travoprost. Doctors choose based on patient response and tolerability.
For patients who cannot tolerate prostaglandin analogues, beta-blockers such as timolol may be considered. Other classes, such as carbonic anhydrase inhibitors, may also be considered, with the most suitable choice determined by your ophthalmologist.
For hypotrichosis, there are limited licensed pharmaceutical alternatives to bimatoprost. Other cosmetic approaches exist but are not prescription medicines. A dermatologist or ophthalmologist can advise on clinical options.
Learn more about prostaglandin analogue treatments for glaucoma management. See available treatment options at your registered UK online pharmacy. Always obtain your medicines from a regulated, MHRA-compliant source.
Possible Side Effects
Like any medicine, bimatoprost carries a risk of side effects, though not all users will be affected. Being aware of what to watch for helps you use the medicine safely.
| Side Effect | Frequency | Notes |
|---|---|---|
| Redness or irritation of the eye or surrounding area | Common | Settles in most patients with continued use |
| Mild itching or burning sensation | Common | Usually mild and short-lived after application |
| Increased tear production | Common | May occur shortly after applying the drops |
| Changes in pigmentation of eyelid skin or lashes | Common | May be lasting even after stopping treatment |
| Gradual change in iris colour | Common | More likely in eyes with mixed or hazel colouring |
| Blurred vision after application | Less Common | Temporary; clears within a few minutes |
| Dry eye symptoms | Less Common | Report to your GP if persistent or uncomfortable |
| Swelling or discomfort around the eye | Less Common | Seek advice if swelling does not settle quickly |
| Headache | Less Common | Monitor frequency and inform your prescriber |
| Intraocular inflammation | Less Common | Contact your ophthalmologist if this is suspected |
Some side effects, such as iris colour change, may be permanent. This risk is higher in patients with hazel or mixed-coloured eyes. Report any change in eye colour to your prescriber promptly.
Urgent medical attention should be sought if severe eye pain, sudden changes to vision, or allergic symptoms occur. Contact your GP or attend A&E if symptoms are serious. Use should be paused until a healthcare professional has been consulted.
Important Safety Advice
Before starting bimatoprost, inform your prescriber of all medicines you currently take. This includes eye drops, topical preparations, and over-the-counter products. Both the safety profile and effectiveness of bimatoprost may be altered by interactions with other medicines.
Drug Interactions
Other eye drops that reduce intraocular pressure may interact with bimatoprost when used at the same time. Combining prostaglandin analogues with similar-class medicines can lead to unexpected effects. Always inform your ophthalmologist of all current eye treatments.
Pregnancy and Breastfeeding
Bimatoprost is not recommended during pregnancy unless a doctor considers it essential. Whether bimatoprost is safe to use during breastfeeding has not yet been fully determined. Pregnancy, plans to conceive, or breastfeeding must all be disclosed to your prescriber before treatment begins.
Medical Conditions to Disclose
- Active or history of ocular inflammation (uveitis or iritis)
- Macular oedema or risk factors for it
- Aphakia (absence of the natural lens)
- Pseudophakia with a torn posterior lens capsule
- Liver or kidney disease
Before applying the solution, lenses must be taken out of the eyes. Reinsertion should be delayed by at least 15 minutes. The preservative benzalkonium chloride in the solution may damage soft contact lenses.
For those under 18 years of age, this medicine is not considered suitable for use. There is insufficient clinical data to support its safety in paediatric patients. Adult medical supervision is required throughout any course of treatment.
Alcohol
No direct interaction between bimatoprost and alcohol has been identified. However, alcohol can increase dryness and irritation in the eye. Take care and follow your prescriber’s guidance.
When Should You Speak to a Doctor?
Contact your GP or ophthalmologist if you notice any sudden changes in vision, severe eye pain, persistent redness, or signs of an allergic reaction, such as swelling of the face or difficulty breathing. Urgent symptoms require immediate attendance at A&E, while symptoms that fail to improve with treatment should prompt a consultation with your doctor. A change in condition may indicate that the medicine needs to be adjusted. Never increase your dose without medical advice.
If you notice any unusual change in eye colour or significant darkening of the eyelid skin, inform your prescriber. Some of these changes may not reverse after stopping treatment. Early assessment is important.
If you accidentally apply bimatoprost to both eyelids or more than the recommended amount, contact your pharmacist or GP. Unless a registered professional has specifically advised it, the eye should not be rinsed with water. Seek guidance promptly.
Can Careprost Be Used With Other Medicines?
Bimatoprost may be used alongside certain other glaucoma medicines under medical supervision. However, using two prostaglandin analogues simultaneously is not recommended. Your ophthalmologist will advise on the safest combination.
All medicines currently being taken — including herbal remedies and supplements — should be disclosed to your pharmacist. Intraocular pressure can be influenced by certain systemic medicines. Potential interactions are best identified with the help of your pharmacist.
Do not use other eye drops within five minutes of bimatoprost unless advised to do so. The order of application can affect how each medicine is absorbed. Follow your prescriber’s instructions precisely.
Storage and Handling Advice
- Store bimatoprost eye drops below 25°C in a cool, dry place
- The bottle should remain tightly closed whenever it is not in use
- At all times, this medicine must be stored where children are unable to see or access it
- The expiry date shown on the label must not be exceeded
- Once the bottle has been opened, any unused solution must be disposed of after four weeks
- Storage in bathrooms or near heat and moisture should be avoided
- The original packaging should be retained to shield the solution from light.
Responsible Access to Treatment
Because bimatoprost is a prescription-only medicine (POM) in the UK, obtaining or supplying it without a valid prescription from a registered prescriber is a breach of the law.
Before any eye treatment is started or changed, a registered UK healthcare professional should be consulted. Obtaining or using medicines prescribed for another person is both unsafe and unlawful under UK law.
Frequently Asked Questions (FAQs)
Q: Is Careprost safe for eyelash growth?
A: Careprost contains bimatoprost 0.03% and is used for eyelash growth under medical supervision. As a prescription-only medicine in the UK, it must only be used following consultation with your GP.
Q: Can Careprost cause eyelid darkening?
A: Yes, bimatoprost can cause darkening of the eyelid skin. This side effect may be permanent in some patients. Contact your GP if you notice any changes to the skin around the eye.
Conclusion
Careprost eyelash serum is an ophthalmic solution in which the active ingredient, bimatoprost 0.03%, belongs to the synthetic prostaglandin analogue class. Raised intraocular pressure associated with open-angle glaucoma and ocular hypertension are the conditions for which it is used. It is also prescribed for eyelash hypotrichosis.
Using bimatoprost without appropriate clinical supervision carries risks. Side effects such as iris colour change and eyelid darkening may be permanent. Consistent follow-up with your ophthalmologist or GP is essential during treatment.
If you have been prescribed this medicine, use it exactly as directed. Treatment should not be discontinued before discussing it with your prescriber. Responsible use under clinical guidance produces the best outcomes.
References
- NHS. Bimatoprost. NHS.uk. Available at: www.nhs.uk
- MHRA. Lumigan 0.03% eye drops solution — Summary of Product Characteristics. MHRA.gov.uk
- NICE. Glaucoma: Diagnosis and Management. NICE guideline NG81. nice.org.uk
- European Medicines Agency (EMA). Lumigan: EPAR — Product Information. EMA.europa.eu
- Higginbotham EJ et al. One-year, randomised study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol. 2002;120(10):1286–93
Medical Disclaimer
This article is for informational purposes only and does not replace professional medical advice. Always consult a registered healthcare professional before starting or changing any treatment.